GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (OTCPK:GMVDF) » Definitions » Enterprise Value

G Medical Innovations Holdings (G Medical Innovations Holdings) Enterprise Value : $2.17 Mil (As of Jun. 10, 2024)


View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, G Medical Innovations Holdings's Enterprise Value is $2.17 Mil. G Medical Innovations Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was $-9.86 Mil. Therefore, G Medical Innovations Holdings's EV-to-EBIT ratio for today is -0.22.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, G Medical Innovations Holdings's Enterprise Value is $2.17 Mil. G Medical Innovations Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 was $-8.65 Mil. Therefore, G Medical Innovations Holdings's EV-to-EBITDA ratio for today is -0.25.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, G Medical Innovations Holdings's Enterprise Value is $2.17 Mil. G Medical Innovations Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 was $4.42 Mil. Therefore, G Medical Innovations Holdings's EV-to-Revenue ratio for today is 0.49.


G Medical Innovations Holdings Enterprise Value Historical Data

The historical data trend for G Medical Innovations Holdings's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings Enterprise Value Chart

G Medical Innovations Holdings Annual Data
Trend Sep16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Enterprise Value
Get a 7-Day Free Trial 15,491.99 13,181.06 67,742.41 27.70 9.61

G Medical Innovations Holdings Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67,742.41 42.24 27.70 18.38 9.61

Competitive Comparison of G Medical Innovations Holdings's Enterprise Value

For the Medical Instruments & Supplies subindustry, G Medical Innovations Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G Medical Innovations Holdings's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's Enterprise Value distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's Enterprise Value falls into.



G Medical Innovations Holdings Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

G Medical Innovations Holdings's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

G Medical Innovations Holdings's Enterprise Value for the quarter that ended in Dec. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G Medical Innovations Holdings  (OTCPK:GMVDF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

G Medical Innovations Holdings's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2.165/-9.864
=-0.22

G Medical Innovations Holdings's current Enterprise Value is $2.17 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. G Medical Innovations Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was $-9.86 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

G Medical Innovations Holdings's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=2.165/-8.652
=-0.25

G Medical Innovations Holdings's current Enterprise Value is $2.17 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. G Medical Innovations Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 was $-8.65 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

G Medical Innovations Holdings's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2.165/4.42
=0.49

G Medical Innovations Holdings's current Enterprise Value is $2.17 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. G Medical Innovations Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 was $4.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G Medical Innovations Holdings Enterprise Value Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


G Medical Innovations Holdings (G Medical Innovations Holdings) Business Description

Traded in Other Exchanges
N/A
Address
5 Oppenheimer Street, Rehovot, ISR, 7670105
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
Executives
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022

G Medical Innovations Holdings (G Medical Innovations Holdings) Headlines

From GuruFocus